Wednesday, March 23, 2022 12:17:55 AM
Fort Worth, TX (March 22, 2022) — PharmChem, Inc. (the “Company”) (OTC: PCHM) today
announced that the Company's Board of Directors has approved a stock repurchase program under
which the Company may repurchase up to 100,000 shares of its common stock at such times and
such prices, as the Company considers to be in the best interests of the Company and its
stockholders, subject to the availability of stock, general market conditions, alternative uses for
capital, and the Company’s financial performance, to be repurchased in open market or private
transactions, through block trades, and pursuant to any trading plan that may be adopted in
accordance with Rule 10b5-1 under the Securities Exchange Act of 1934. This stock repurchase
program has no expiration date and replaces the previous stock repurchase program.
https://s3.amazonaws.com/com-pharmcheck-cdn/document-uploads/PharmChem-Share-Repurchase-Press-Release-March-22-2022.pdf?mtime=20220322163030
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM